CURE HEARTandBRAIN CURE HEARTandBRAIN postdoctoral COFUND programme by CNIC
- Coordinator
- Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (f.s.p.), Spain
- Runs
- 1 January 2024 to 31 December 2028
- Status
- Running
- EU funding
- €1.7m
- Total cost
- —
- Partners
- 25 organisations in 8 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101126521
What the project is doing
In the project's own words, from its summary on CORDIS.
The CNIC (Spanish Centre for Cardiovascular Research) is a worldwide recognised research centre dedicated to cardiovascular research. CNIC’s mission is to improve cardiovascular health in the society by generating scientific knowledge, efficiently translating that knowledge to the clinic, and providing new researchers with a comprehensive training. CNIC, awarded with the HR Excellence in Research since 2013, proposes to run a postdoctoral fellowship programme “CURE HEART & BRAIN” that will offer a total of 12 positions in the incoming mobility type for the selected and eligible candidates (holding PhD and compliant with MSCA mobility rules).
During the COFUND grant life (5 years) there will be two calls (M2 and M9), each offering 6 fellowships. The Programme will advertise the positions internationally. The fellows will be able to choose the supervisor at CNIC and to propose research projects in all the research disciplines available at CNIC. The selection of the proposals will be transparent, based on merit and performed by external international peer-reviewers.
CURE HEART & BRAIN fellowship programme will be open to excellent researchers of any nationality. The programme will offer training to develop key transferable skills and competences, foster innovation, entrepreneurship, promote Open Science practices, FAIR data management, and public engagement. The fellows will acquire new skills through advanced training, international, interdisciplinary and inter-sectoral mobility.
CURE HEART & BRAIN includes 24 Associated Partners (12 from private sector) from all over the world and from different sectors, providing translational elements to the programme (secondments, training, supervision). The overall goal of the programme is to enhance the creative and innovative potential of a new generation of translational researchers in cardiovascular research and related areas as well as reach out to society to make the results of the research visible to the citizens.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (f.s.p.) | Madrid | Spain | Coordinator |
| Charite - Universitaetsmedizin Berlin | Berlin | Germany | Associatedpartner |
| Michael Nyberg | Bagsvaerd | Denmark | Associatedpartner |
| Aptatargets SL | Madrid | Spain | Associatedpartner |
| Aptus Biotech SL | Madrid | Spain | Associatedpartner |
| BioAssays SL | Madrid | Spain | Associatedpartner |
| Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I Sunyer | Barcelona | Spain | Associatedpartner |
| Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon | Madrid | Spain | Associatedpartner |
| Fundacion Para La Investigacion Biomedica Del Hospital Universitario 12 De Octubre | Madrid | Spain | Associatedpartner |
| Fundacion Para La Investigacion Biomedica Del Hospital Universitario Clinico San Carlos | Madrid | Spain | Associatedpartner |
| Fundacion Para La Investigacion Biomedica Del Hospital Universitario Puerta De Hierro-Majadahonda | Majadahonda | Spain | Associatedpartner |
| Health in Code SL | Valencia | Spain | Associatedpartner |
| Idoven 1903 SL | Madrid | Spain | Associatedpartner |
| Instituto Investigacion Sanitaria Fundacion Jimenez Diaz | Madrid | Spain | Associatedpartner |
| Philips Iberica SA | Madrid | Spain | Associatedpartner |
| Istituti Clinici Scientifici Maugeri Societa' per Azioni Societa' Benefit | Pavia | Italy | Associatedpartner |
| Universita Humanitas | Pieve Emanuele | Italy | Associatedpartner |
| Stichting Amsterdam Umc | Amsterdam | Netherlands | Associatedpartner |
| Astrazeneca AB | Sodertaelje | Sweden | Associatedpartner |
| Imperial College Healthcare NHS Trust | London | United Kingdom | Associatedpartner |
| Salford Royal NHS Foundation Trust | Salford | United Kingdom | Associatedpartner |
| Albert Einstein College of Medicine, Inc. | Bronx | United States | Associatedpartner |
| Icahn School of Medicine at Mount Sinai | New York | United States | Associatedpartner |
| Mayo Clinic | Rochester | United States | Associatedpartner |
| The General Hospital Corporation | Boston Ma | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI